BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31031188)

  • 1. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
    Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
    Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction.
    Muntean AG; Chen W; Jones M; Granowicz EM; Maillard I; Hess JL
    Blood; 2013 Sep; 122(11):1914-22. PubMed ID: 23900238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
    Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of
    Ropa J; Saha N; Chen Z; Serio J; Chen W; Mellacheruvu D; Zhao L; Basrur V; Nesvizhskii AI; Muntean AG
    Oncotarget; 2018 Apr; 9(31):22123-22136. PubMed ID: 29774127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeodomain transcription factor Meis1 is a critical regulator of adult bone marrow hematopoiesis.
    Ariki R; Morikawa S; Mabuchi Y; Suzuki S; Nakatake M; Yoshioka K; Hidano S; Nakauchi H; Matsuzaki Y; Nakamura T; Goitsuka R
    PLoS One; 2014; 9(2):e87646. PubMed ID: 24498346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
    Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion.
    Miller ME; Rosten P; Lemieux ME; Lai C; Humphries RK
    PLoS One; 2016; 11(3):e0151584. PubMed ID: 26986211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress.
    Unnisa Z; Clark JP; Roychoudhury J; Thomas E; Tessarollo L; Copeland NG; Jenkins NA; Grimes HL; Kumar AR
    Blood; 2012 Dec; 120(25):4973-81. PubMed ID: 23091297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.
    Hess JL; Bittner CB; Zeisig DT; Bach C; Fuchs U; Borkhardt A; Frampton J; Slany RK
    Blood; 2006 Jul; 108(1):297-304. PubMed ID: 16507773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.
    Pineault N; Helgason CD; Lawrence HJ; Humphries RK
    Exp Hematol; 2002 Jan; 30(1):49-57. PubMed ID: 11823037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
    Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
    Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
    Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
    Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.